Efficacy and Safety of Ivabradine to Reduce Heart Rate Prior to Coronary CT-angiography in Advanced Heart Failure: Comparison With β-Blocker
Randomized Clinical Trial of Ivabradine to Reduce Heart Rate Prior to Coronary CT-angiography in Advanced Heart Failure: Comparison With β-Blocker
1 other identifier
interventional
200
1 country
1
Brief Summary
The aim of this study is to compare the effects of Ivabradine and metoprolol to reduce heart rate prior to coronary CT angiography in patients with advanced heart failure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable heart-failure
Started Nov 2018
Shorter than P25 for not_applicable heart-failure
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 26, 2018
CompletedStudy Start
First participant enrolled
November 26, 2018
CompletedFirst Posted
Study publicly available on registry
February 5, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2019
CompletedApril 12, 2019
April 1, 2019
1 year
November 26, 2018
April 10, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Heart rate
Changing heart rate during imaging study
30 minutes before and after coronary CT angiography
Secondary Outcomes (7)
Dyspnea
30 minutes before and after coronary CT angiography and 6 months later
Functional calss
30 minutes before and after coronary CT angiography and 6 months later
Blood pressure, systolic and diastolic
30 minutes before and after coronary CT angiography and 6 months later
Sleep quality
Before CT angiography and 6 months later
Appetite
Before CT angiography and 6 months later
- +2 more secondary outcomes
Study Arms (2)
Ivabradine
ACTIVE COMPARATORmetoprolol
ACTIVE COMPARATORInterventions
7.5 mg oral single dose if the heart rate would not reach to 60/minute then give another dose, 7.5 mg
5 mg oral single dose if the heart rate would not reach to 60/minute then give another dose, 5 mg
Eligibility Criteria
You may qualify if:
- Sinus rhythm
- Heart rate \>60/min
You may not qualify if:
- Atrial fibrillation
- Any contraindication for beta-blocker use
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ahmad Amin
Tehran, 1996911151, Iran
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, CARE PROVIDER
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 26, 2018
First Posted
February 5, 2019
Study Start
November 26, 2018
Primary Completion
December 1, 2019
Study Completion
December 1, 2019
Last Updated
April 12, 2019
Record last verified: 2019-04